ASHLEY CRISOSTOMO: Open Payments
NPI 1356862791 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,538 in 67 payments from 22 companies in 2025. Trend: 2023 $635 · 2024 $1,263 · 2025 $1,538
Food & beverage: $1,538
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $340 |
| Novo Nordisk Inc | 11 | $259 |
| AstraZeneca Pharmaceuticals LP | 7 | $153 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $97 |
| Corcept Therapeutics | 4 | $95 |
| Amgen Inc. | 3 | $72 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Lilly USA, LLC | 2 | $44 |
Products named: VRAYLAR, Ozempic, JARDIANCE, Kerendia, BREZTRI, Korlym, QULIPTA, EVENITY.
Industry payments across CA — which companies pay providers there.
